First-in-Human Dose Escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1013575

• Contact name

  Millicent Sifuna

• Contact email

  millie.x.sifuna@gsk.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Clinicaltrials.gov Identifier

  NCT07646353

• Research summary

  Publication of this data is currently deferred.

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  26/NW/0021

• Date of REC Opinion

  16 Apr 2026

• REC opinion

  Further Information Favourable Opinion